Rheumatoid Arthritis (RA) Market

Oct 05, 2020

10 likes | 38 Views

In 2017, the total prevalent cases of Rheumatoid Arthritis in 7MM was 4,356,793. The prevalent cases of Rheumatoid Arthritis in the United States was 1,333,290, while Germany had 836,101 prevalent cases in 2017. The market size of Rheumatoid Arthritis in 7MM was USD 21.2 Billion in 2017. Increase in the prevalence population of Rheumatoid Arthritis, increase in geriatric population and rich emerging pipeline are some of the key factors expected to drive the Rheumatoid Arthritis market in the coming years. Some of the key players in the Rheumatoid Arthritis include GlaxoSmithKline, Gilead and Galapagos NV, R-Pharm, Taisho Pharmaceuticals, Aclaris Therapeutics, Viela Bio, Bristol Myers Squibb, AbbVie, Pfizer/Philogen, Akros Pharma/Japan Tobacco, Merck KGaA, Genentech (subsidiary of Roche), Mesoblast, UCB Pharma/PRA HEALTH SCIENCES, Izana Bioscience/Takeda, Abivax S.A., Hope Biosciences and Genosco (Oscotec). For more details, visit: https://www.delveinsight.com/report-store/rheumatoid-arthritis-ra-market

DelveInsight

Download Presentation

Rheumatoid Arthritis (RA) Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D